Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

NCT06728839 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1329

Last updated 2024-12-11

No results posted yet for this study

Summary

Magnesium salts such as magnesium citrate are often combined with polyethylene glycol to make the intestinal preparation before colonoscopy, which has shown high cleaning efficacy. Magnesium sulfate combined with polyethylene glycol is less used in the world. This multicenter, randomized, controlled trial is aimed at to evaluate the efficacy and safety of magnesium sulfate combined with low-volume polyethylene glycol for preoperative bowel preparation for colonoscopy.

Conditions

  • Bowel Preparation for Colonoscopy

Interventions

DRUG

1L PEG + 50g magnesium sulfate

Subjects in Group A will use a regimen combining magnesium sulfate and polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. 1 litter of polyethylene glycol is taken at 8pm the day before the colonoscopy and 50 gram of magnesium sulfate is taken 4-6 hours before the colonoscopy, and then drink 2000 ml of water within 2 hours.

DRUG

3L PEG

Subjects in Group B will use a regimen with 3L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 3 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.

DRUG

4L PEG

Subjects in Group C will use a regimen with 4L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 4 liters of polyethylene glycol solution is taken in split dosing, with 2 liters taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.

Sponsors & Collaborators

  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • Daping Hospital of Army Medical University

    collaborator OTHER
  • Ningjin People's Hospital

    collaborator UNKNOWN
  • Zibo Central Hospital

    collaborator OTHER_GOV
  • Zhengzhou Central Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Affiliated Yueqing Hospital of Wenzhou Medical University

    collaborator OTHER
  • Qianfoshan Hospital

    collaborator OTHER
  • The General Hospital of Western Theater Command

    collaborator OTHER
  • Jiangmen Central Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Henan University of Science and Technology

    collaborator OTHER
  • LiuZhou People's Hospital

    collaborator OTHER
  • The Fifth Affiliated Hospital of Zunyi Medical College

    collaborator OTHER
  • Yan'an University Affiliated Hospital

    collaborator OTHER
  • 900 Hospital of Joint Logistics Support Force of PLA

    collaborator OTHER
  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Zhaoshen Li, MD · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-09
Primary Completion
2025-08-31
Completion
2025-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06728839 on ClinicalTrials.gov